Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Hans-Henrik Parving; Barry M Brenner; John J V McMurray; Dick de Zeeuw; Steven M Haffner; Scott D Solomon; Nish Chaturvedi; Frederik Persson; Akshay S Desai; Maria Nicolaides; Alexia Richard; Zhihua Xiang; Patrick Brunel; Marc A Pfeffer

doi:10.1056/NEJMoa1208799

Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Hans-Henrik Parving, Barry M Brenner, John J V McMurray, Dick de Zeeuw, Steven M Haffner, Scott D Solomon, Nish Chaturvedi, Frederik Persson, Akshay S Desai, Maria Nicolaides, Alexia Richard, Zhihua Xiang, Patrick Brunel, Marc A Pfeffer

Department of Internal Medicine I- Division of Gastroenterology, Hepatology, Nephrology, Metabolism and Diabetologylog

Research output: Contribution to journal › Original Article › peer-review

967 Citations (Web of Science)

Original language	English
Pages (from-to)	2204-2213
Journal	NEW ENGLAND JOURNAL OF MEDICINE
Volume	367
Issue number	23
DOIs	https://doi.org/10.1056/NEJMoa1208799
Publication status	Published - 2012

Keywords

GLOMERULAR-FILTRATION-RATE
CONVERTING-ENZYME INHIBITORS
LEFT-VENTRICULAR DYSFUNCTION
CHRONIC HEART-FAILURE
MYOCARDIAL-INFARCTION
DOUBLE-BLIND
CARDIOVASCULAR MORTALITY
SYSTOLIC DYSFUNCTION
BLOOD-PRESSURE
FOLLOW-UP

Access to Document

10.1056/NEJMoa1208799

Cite this

Parving, H.-H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Persson, F., Desai, A. S., Nicolaides, M., Richard, A., Xiang, Z., Brunel, P., & Pfeffer, M. A. (2012). Cardiorenal end points in a trial of aliskiren for type 2 diabetes. NEW ENGLAND JOURNAL OF MEDICINE , 367(23), 2204-2213. https://doi.org/10.1056/NEJMoa1208799

Parving, Hans-Henrik ; Brenner, Barry M ; McMurray, John J V et al. / Cardiorenal end points in a trial of aliskiren for type 2 diabetes. In: NEW ENGLAND JOURNAL OF MEDICINE 2012 ; Vol. 367, No. 23. pp. 2204-2213.

@article{997172201e274ba4920916a755ed723b,

title = "Cardiorenal end points in a trial of aliskiren for type 2 diabetes.",

keywords = "GLOMERULAR-FILTRATION-RATE, CONVERTING-ENZYME INHIBITORS, LEFT-VENTRICULAR DYSFUNCTION, CHRONIC HEART-FAILURE, MYOCARDIAL-INFARCTION, DOUBLE-BLIND, CARDIOVASCULAR MORTALITY, SYSTOLIC DYSFUNCTION, BLOOD-PRESSURE, FOLLOW-UP",

author = "Hans-Henrik Parving and Brenner, {Barry M} and McMurray, {John J V} and {de Zeeuw}, Dick and Haffner, {Steven M} and Solomon, {Scott D} and Nish Chaturvedi and Frederik Persson and Desai, {Akshay S} and Maria Nicolaides and Alexia Richard and Zhihua Xiang and Patrick Brunel and Pfeffer, {Marc A}",

year = "2012",

doi = "10.1056/NEJMoa1208799",

language = "English",

volume = "367",

pages = "2204--2213",

journal = "NEW ENGLAND JOURNAL OF MEDICINE ",

issn = "0028-4793",

publisher = "Massachusetts Medical Soc",

number = "23",

}

Parving, H-H, Brenner, BM, McMurray, JJV, de Zeeuw, D, Haffner, SM, Solomon, SD, Chaturvedi, N, Persson, F, Desai, AS, Nicolaides, M, Richard, A, Xiang, Z, Brunel, P & Pfeffer, MA 2012, 'Cardiorenal end points in a trial of aliskiren for type 2 diabetes.', NEW ENGLAND JOURNAL OF MEDICINE , vol. 367, no. 23, pp. 2204-2213. https://doi.org/10.1056/NEJMoa1208799

Cardiorenal end points in a trial of aliskiren for type 2 diabetes. / Parving, Hans-Henrik; Brenner, Barry M; McMurray, John J V et al.
In: NEW ENGLAND JOURNAL OF MEDICINE , Vol. 367, No. 23, 2012, p. 2204-2213.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

AU - Parving, Hans-Henrik

AU - Brenner, Barry M

AU - McMurray, John J V

AU - de Zeeuw, Dick

AU - Haffner, Steven M

AU - Solomon, Scott D

AU - Chaturvedi, Nish

AU - Persson, Frederik

AU - Desai, Akshay S

AU - Nicolaides, Maria

AU - Richard, Alexia

AU - Xiang, Zhihua

AU - Brunel, Patrick

AU - Pfeffer, Marc A

PY - 2012

Y1 - 2012

KW - GLOMERULAR-FILTRATION-RATE

KW - CONVERTING-ENZYME INHIBITORS

KW - LEFT-VENTRICULAR DYSFUNCTION

KW - CHRONIC HEART-FAILURE

KW - MYOCARDIAL-INFARCTION

KW - DOUBLE-BLIND

KW - CARDIOVASCULAR MORTALITY

KW - SYSTOLIC DYSFUNCTION

KW - BLOOD-PRESSURE

KW - FOLLOW-UP

U2 - 10.1056/NEJMoa1208799

DO - 10.1056/NEJMoa1208799

M3 - Original Article

C2 - 23121378

SN - 0028-4793

VL - 367

SP - 2204

EP - 2213

JO - NEW ENGLAND JOURNAL OF MEDICINE

JF - NEW ENGLAND JOURNAL OF MEDICINE

IS - 23

ER -

Parving HH, Brenner BM, McMurray JJV, de Zeeuw D, Haffner SM, Solomon SD et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. NEW ENGLAND JOURNAL OF MEDICINE . 2012;367(23):2204-2213. doi: 10.1056/NEJMoa1208799